Finch Therapeutics Group Inc reports results for the quarter ended in March - Earnings Summary

Finch Therapeutics

13/05/2021 20:00

* Finch Therapeutics Group Inc  FNCH.OQ  reported a quarterly
adjusted loss of 100 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 24 cents per share.
* Revenue was $3.55 million​;  analysts expected zero. 
* Finch Therapeutics Group Inc's reported EPS for the quarter
was a loss of $1.00​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Finch Therapeutics Group Inc shares had fallen by 24.0% this
quarter.
* The company reported a quarterly loss of $13.98 million.
* Wall Street's median 12-month price target for Finch
Therapeutics Group Inc is $29.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 07:00 p.m. GMT.
​All figures in US dollars